Substituted Piperazines as Novel Potential Radioprotective Agents

Area of Science:

• Medicinal Chemistry
• Radiation Biology
• Pharmacology

Background:

• Growing concerns about radiation exposure necessitate the development of effective radioprotective agents.
• Piperazine derivatives have shown potential in previous studies for radioprotection.

Purpose of the Study:

• To design and synthesize novel 1-(2-hydroxyethyl)piperazine derivatives.
• To evaluate the radioprotective efficacy and cytotoxicity of these novel compounds.

Main Methods:

• Chemical synthesis of novel piperazine derivatives.
• In vitro assessment of cell survival and apoptosis in human cells post-irradiation.
• In vivo evaluation of compound toxicity and survival rates in mice after irradiation.

Main Results:

• Several synthesized compounds demonstrated protection against radiation-induced apoptosis in human cells with low cytotoxicity.
• Compound 8 exhibited significant radioprotective effects on cell survival in vitro and low toxicity in vivo.
• Compound 8 showed a trend towards enhanced survival in mice 30 days post-irradiation, though not statistically significant.

Conclusions:

• The novel 1-(2-hydroxyethyl)piperazine derivatives show potential as radioprotective agents.
• Compound 8 is a promising candidate for further research and development as a radioprotector.
• Further studies are warranted to optimize and validate these compounds for clinical applications.